Doug Hampton 
WASHINGTON, June 1, 2023 /PRNewswire/ — Today, the Pharmaceutical Research and Manufacturers of American (PhRMA) is highlighting a new analysis from Partnership for Health Analytic Research (PHAR) that demonstrates how the price setting provisions in the Inflation Reduction Act (IRA) acutely impact the research and development (R&D) of cancer medicines. Timing of post-approval indications Types … Read more
Scanning electron microscopy (SEM) in general can be used to explore intricate, ultrastructural 3D information with various methods collectively known as volume EM (vEM). Serial block-face SEM (SBF-SEM) is the vEM technology of choice for researchers who prefer easy sample preparation in combination with a highly automated imaging process enabling the acquisition of large volume … Read more
Clinical-Stage Company Focused on Advancing Fibroblast Cell-Based Therapies for Treatment of Chronic Diseases HOUSTON, June 1, 2023 /PRNewswire/ — FibroBiologics, a clinical-stage company focused on the development of fibroblast cell-based therapeutics for chronic diseases, today announced that Pete O’Heeron, Founder and Chief Executive Officer, will present a corporate overview next week at the 2023 BIO International … Read more
DALLAS, June 1, 2023 /PRNewswire/ — Susan G. Komen®, the world’s leading breast cancer organization, and Expedia®, one of the world’s leading full-service travel brands, are offering individuals an opportunity to help raise critical funds for breast cancer when they book their travel with Expedia, just in time for the upcoming summer travel season. The new, … Read more
DUBLIN, June 1, 2023 /PRNewswire/ — Medtronic plc (NYSE:MDT) today announced that Ken Washington, Ph.D., has been appointed Medtronic Chief Technology and Innovation Officer. In this newly created role, Dr. Washington will leverage his extensive experience leading technology development and execution across industries including robotics, consumer products, automotive, and space, to accelerate innovation-driven growth in … Read more
CAMBRIDGE, Mass., June 1, 2023 /PRNewswire/ — Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted four newly-hired employees options to purchase an aggregate of 29,000 shares of Akebia’s common stock on May 31, 2023, as inducements material to such employee entering … Read more
PHOENIX, June 1, 2023 /PRNewswire/ — Trinity Capital Inc. (NASDAQ: TRIN) (“Trinity” or the “Company”), a leading provider of diversified financial solutions to growth-stage companies, today announced the commitment of $30 million in growth capital to support Revelle’s efforts in developing aesthetic solutions that deliver meaningful results for women and reliable outcomes for practitioners. Revelle … Read more
GAITHERSBURG, Md., June 1, 2023 /PRNewswire/ — Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, today announced that it will participate in the Jefferies Global Healthcare Conference. Conference Details: Fireside Chat Date: Thursday, June 8, 2023 Time: 9:00 – 9:25 a.m. Eastern Daylight Time (EDT) Location: New York, … Read more
CHADDS FORD, Pa., June 1, 2023 /PRNewswire/ — MOBILion Systems Inc., pioneers of next generation separation science, will be highlighting a number of advances at the 71st Annual American Society for Mass Spectrometry (ASMS) conference being held June 4th to June 8th in Houston, Texas. MOBILion’s high-resolution ion mobility product, MOBIE®, provides the industry’s highest resolution, full … Read more
Researchers using advanced brain imaging are first to find increase in protein marker of inflammation in illness affecting 200 million globally TORONTO, June 1, 2023 /PRNewswire/ — A new CAMH study published in the journal JAMA Psychiatry found elevated levels of inflammation in the brain of patients who report persistent symptoms of long COVID. Using … Read more